Commentary on “Weekly Low‐Dose Versus Three‐Weekly High‐Dose Cisplatin for Concurrent Chemoradiation in Locoregionally Advanced Non‐Nasopharyngeal Head and Neck Cancer: A Systemati...

Por Colevas, A. Dimitrios
Publicado no Oncologist (2017)

The Use of Epidermal Growth Factor Receptor Monoclonal Antibodies in Squamous Cell Carcinoma of the Head and Neck

Por Russell, Jeffery S., Colevas, A. Dimitrios
Publicado em 2012

Differentiated Thyroid Cancer: Focus on Emerging Treatments for Radioactive Iodine-Refractory Patients

Por Gruber, Joshua J., Colevas, A. Dimitrios
Publicado no Oncologist (2015)

Balancing Safety and Efficacy of Epidermal Growth Factor Receptor Inhibitors in Patients With Squamous Cell Carcinoma of the Head and Neck

Por Iberri, David J., Colevas, A. Dimitrios
Publicado no Oncologist (2015)

Balancing Safety and Efficacy of Epidermal Growth Factor Receptor Inhibitors in Patients With Squamous Cell Carcinoma of the Head and Neck

Por Iberri, David J., Colevas, A. Dimitrios
Publicado no Oncologist (2016)

Assessing Care Value for Older Patients Receiving Radiotherapy With or Without Cisplatin or Cetuximab for Locoregionally Advanced Head and Neck Cancer

Por Saraswathula, Anirudh, Chen, Michelle M., Colevas, A. Dimitrios, Divi, Vasu
Publicado no JAMA Otolaryngol Head Neck Surg (2019)

Metastatic cutaneous squamous cell carcinoma responsive to cemiplimab in a patient with multiple myeloma

Por Marukian, Nareh Valerie, Lin, John Q., Colevas, A. Dimitrios, Coutre, Steven, Chang, Anne Lynn S.
Publicado no JAAD Case Rep (2020)

Development and validation of radiomic signatures of head and neck squamous cell carcinoma molecular features and subtypes

Por Huang, Chao, Cintra, Murilo, Brennan, Kevin, Zhou, Mu, Colevas, A. Dimitrios, Fischbein, Nancy, Zhu, Shankuan, Gevaert, Olivier
Publicado no EBioMedicine (2019)

CT-based Radiomic Signatures for Predicting Histopathologic Features in Head and Neck Squamous Cell Carcinoma

Por Mukherjee, Pritam, Cintra, Murilo, Huang, Chao, Zhou, Mu, Zhu, Shankuan, Colevas, A. Dimitrios, Fischbein, Nancy, Gevaert, Olivier
Publicado no Radiol Imaging Cancer (2020)

Eruptive Keratoacanthomas Associated With Pembrolizumab Therapy

Por Freites-Martinez, Azael, Kwong, Bernice Y., Rieger, Kerri E., Coit, Daniel G., Colevas, A. Dimitrios, Lacouture, Mario E.
Publicado no JAMA Dermatol (2017)

Weekly Docetaxel, Cisplatin, and Cetuximab in Palliative Treatment of Patients with Squamous Cell Carcinoma of the Head and Neck

Por Trieu, Vanessa, Pinto, Harlan, Riess, Jonathan W., Lira, Ruth, Luciano, Richard, Coty, Jessie, Boothroyd, Derek, Colevas, A. Dimitrios
Publicado no Oncologist (2018)

Phase I Study of Continuous Weekly Dosing of Dimethylamino Benzoylphenylurea (BPU) in Patients with Solid Tumours

Por Messersmith, Wells A., Rudek, Michelle A., Baker, Sharyn D., Zhao, Ming, Collins, Connie, Colevas, A. Dimitrios, Donehower, Ross C., Carducci, Michael A., Wolff, Antonio C.
Publicado em 2006

The Sentinel Margin: Intraoperative ex-vivo Specimen Mapping Using Relative Fluorescence Intensity

Por van Keulen, Stan, Nishio, Naoki, Birkeland, Andrew, Fakurnejad, Shayan, Martin, Brock, Forouzanfar, Tim, Cunanan, Kristen, Colevas, A. Dimitrios, van den Berg, Nynke Sjoerdje, Rosenthal, Eben
Publicado no Clin Cancer Res (2019)

Fluorescence molecular imaging for identification of high-grade dysplasia in patients with head and neck cancer

Por Fakurnejad, Shayan, van Keulen, Stan, Nishio, Naoki, Engelen, Myrthe, van den Berg, Nynke S., Lu, Guolan, Birkeland, Andrew, Baik, Fred, Colevas, A. Dimitrios, Rosenthal, Eben L., Martin, Brock A.
Publicado no Oral Oncol (2019)

A pooled analysis of advanced nonsquamous non-small cell lung cancer patients with stable treated brain metastases in two phase II trials receiving bevacizumab and pemetrexed as se...

Por Gubens, Matthew A., Chuang, Jody C., Akerley, Wallace, Langer, Corey J., Clément-Duchêne, Christelle, San Pedro-Salcedo, Melanie, Colevas, A. Dimitrios, Dragnev, Konstantin, Socinski, Mark A., Wakelee, Heather A.
Publicado no J Thorac Dis (2018)

Validation that Metabolic Tumor Volume Predicts Outcome in Head and Neck Cancer

Por Tang, Chad, Murphy, James D., Khong, Brian, La, Trang H., Kong, Christina, Fischbein, Nancy J., Colevas, A. Dimitrios, Iagaru, Andrei H., Graves, Edward E., Loo, Billy W., Le, Quynh-Thu
Publicado em 2012

Phase I trial of ixabepilone administered as three oral doses each separated by 6 hours every 3 weeks in patients with advanced solid tumors

Por Kunz, Pamela L., He, Aiwu R., Colevas, A. Dimitrios, Pishvaian, Michael J., Hwang, Jimmy J., Clemens, Pamela L., Messina, Marianne, Kaleta, Remigiusz, Abrahao, Fernanda, Sikic, Branimir I., Marshall, John L.
Publicado em 2012

A Phase II First-Line Study of Gemcitabine, Carboplatin, and Bevacizumab in Advanced Stage Non-squamous Non-small Cell Lung Cancer

Por Clément-Duchêne, Christelle, Krupitskaya, Yelena, Ganjoo, Kristen, Lavori, Philip, McMillan, Alex, Kumar, Atul, Zhao, Gary, Padda, Sukhmani, Zhou, Lisa, Pedro-Salcedo, Melanie San, Colevas, A. Dimitrios, Wakelee, Heather A.
Publicado no J Thorac Oncol (2010)

Effects of Combined Treatment With Arsenic Trioxide and Itraconazole in Patients With Refractory Metastatic Basal Cell Carcinoma

Por Ally, Mina S., Ransohoff, Katherine, Sarin, Kavita, Atwood, Scott X., Rezaee, Melika, Bailey-Healy, Irene, Kim, Jynho, Beachy, Philip A., Chang, Anne Lynn S., Oro, Anthony, Tang, Jean Y., Colevas, A. Dimitrios
Publicado no JAMA Dermatol (2016)

Phase II Study of the Addition of Bevacizumab to Standard Chemoradiation for Loco-regionally Advanced Nasopharyngeal Carcinoma: Radiation Therapy Oncology Group (RTOG) Trial 0615

Por Lee, Nancy Y., Zhang, Ed, Pfister, David. G., Kim, John, Garden, Adam. S., Mechalakos, James, Hu, Kenneth, Le, Quynh T., Colevas, A. Dimitrios, Glisson, Bonnie S., Chan, Anthony T.C., Ang, K. Kian
Publicado no Lancet Oncol (2011)